Syrma SGS Technology plans to reach $1 billion in revenue by FY28 after reporting a 74% surge in second-quarter revenue. The electronics manufacturer is expanding capacity to overcome persistent supply chain bottlenecks, though investors should note the high capital intensity of this growth strategy.
Syrma SGS Technology has set a significant financial goal, aiming for $1 billion in annual revenue by the end of fiscal year 2028. This long-term objective follows a strong fiscal second quarter in 2026, where the company reported revenue of nearly ₹2,000 crore, representing a 74% increase compared to the previous year. Profitability also saw a sharp improvement, with net profit rising by 87% to ₹124 crore.
The company’s recent performance was supported by broad-based growth across its key business divisions. The automotive sector was a major contributor, with revenue jumping 91% to ₹517 crore. Additionally, the company’s Original Design and Manufacturing (ODM) segment doubled its contribution in the first half of the fiscal year, reaching ₹591 crore. Exports have also become a critical pillar of this growth strategy, now accounting for 26% of the company's total revenue. Sales to key markets in the US and Europe grew by 91% year-over-year, indicating a successful expansion of the firm's global presence.
Despite this strong growth, the business continues to navigate operational hurdles. The management has highlighted ongoing tightness in the supply of active components, such as chips and memory controllers. Furthermore, Printed Circuit Boards (PCBs) have acted as a production bottleneck, which can impact delivery timelines. These supply chain issues are common in the electronics manufacturing services sector, where companies rely on a complex network of global component suppliers.
To address these production challenges and support its revenue targets, the company is investing heavily in new infrastructure. A key component of this plan is a new PCB manufacturing facility in Andhra Pradesh, which is expected to be operational by March 2027. This plant is intended to reduce reliance on external suppliers and provide greater control over production schedules. The company is also expanding its physical footprint through a joint venture in Bengaluru with Elemaster S P A Tecnologie Elettroniche and a new facility for medical plastics and precision moulding in Jodhpur through its subsidiary, Syrma Johari MedTech.
For investors, these developments highlight both the company's growth potential and the risks inherent in its strategy. The aggressive capital spending required to build and scale these facilities is a major monitorable. While expansion is necessary to reach the $1 billion revenue mark, heavy spending can put pressure on cash flow and profit margins in the short term. The ability to execute these projects on time without significant cost overruns will be a crucial factor. Investors may track the commissioning status of the new plants, the trend in debt levels, and whether the company can maintain its profit margins as it scales its operations in a competitive and supply-constrained environment.